These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 17712842)

  • 21. Riluzole in cerebellar ataxia: a randomized, double-blind, placebo-controlled pilot trial.
    Ristori G; Romano S; Visconti A; Cannoni S; Spadaro M; Frontali M; Pontieri FE; Vanacore N; Salvetti M
    Neurology; 2010 Mar; 74(10):839-45. PubMed ID: 20211908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative evaluation of balance in patients with spinocerebellar ataxia type 1: a case control study.
    Mohan G; Pal PK; Sendhil KR; Thennarasu K; Usha BR
    Parkinsonism Relat Disord; 2009 Jul; 15(6):435-9. PubMed ID: 19028133
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of cerebellar ataxia in chronic alcoholics using the International Cooperative Ataxia Rating Scale (ICARS).
    Fitzpatrick LE; Jackson M; Crowe SF
    Alcohol Clin Exp Res; 2012 Nov; 36(11):1942-51. PubMed ID: 22568470
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of a brief ataxia rating scale (BARS) based on a modified form of the ICARS.
    Schmahmann JD; Gardner R; MacMore J; Vangel MG
    Mov Disord; 2009 Sep; 24(12):1820-8. PubMed ID: 19562773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and validation of the Unified Multiple System Atrophy Rating Scale (UMSARS).
    Wenning GK; Tison F; Seppi K; Sampaio C; Diem A; Yekhlef F; Ghorayeb I; Ory F; Galitzky M; Scaravilli T; Bozi M; Colosimo C; Gilman S; Shults CW; Quinn NP; Rascol O; Poewe W;
    Mov Disord; 2004 Dec; 19(12):1391-402. PubMed ID: 15452868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of multiple-session delay eyeblink conditioning comparing patients with focal cerebellar lesions and cerebellar degeneration.
    Gerwig M; Guberina H; Esser AC; Siebler M; Schoch B; Frings M; Kolb FP; Aurich V; Beck A; Forsting M; Timmann D
    Behav Brain Res; 2010 Oct; 212(2):143-51. PubMed ID: 20385171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validity and Reliability of the Korean-Translated Version of the International Cooperative Ataxia Rating Scale in Cerebellar Ataxia.
    Park J; Cho JW; Youn J; Oh E; Jang W; Kim JS; Oh YS; Hwang H; Ryu CH; Ahn JY; Lee JY; Koh SB; Park JH; Kim HT
    J Mov Disord; 2023 Jan; 16(1):86-90. PubMed ID: 36537063
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Movement disorder-childhood rating scale: reliability and validity.
    Battini R; Sgandurra G; Petacchi E; Guzzetta A; Di Pietro R; Giannini MT; Leuzzi V; Mercuri E; Cioni G
    Pediatr Neurol; 2008 Oct; 39(4):259-65. PubMed ID: 18805364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of the oral form of ondansetron on cerebellar dysfunction. A multi-center double-blind study.
    Bier JC; Dethy S; Hildebrand J; Jacquy J; Manto M; Martin JJ; Seeldrayers P
    J Neurol; 2003 Jun; 250(6):693-7. PubMed ID: 12796831
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Composite cerebellar functional severity score: validation of a quantitative score of cerebellar impairment.
    du Montcel ST; Charles P; Ribai P; Goizet C; Le Bayon A; Labauge P; Guyant-Maréchal L; Forlani S; Jauffret C; Vandenberghe N; N'guyen K; Le Ber I; Devos D; Vincitorio CM; Manto MU; Tison F; Hannequin D; Ruberg M; Brice A; Durr A
    Brain; 2008 May; 131(Pt 5):1352-61. PubMed ID: 18378516
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The gait variability index: a new way to quantify fluctuation magnitude of spatiotemporal parameters during gait.
    Gouelle A; Mégrot F; Presedo A; Husson I; Yelnik A; Penneçot GF
    Gait Posture; 2013 Jul; 38(3):461-5. PubMed ID: 23889886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Spastic Paraplegia Rating Scale (SPRS): a reliable and valid measure of disease severity.
    Schüle R; Holland-Letz T; Klimpe S; Kassubek J; Klopstock T; Mall V; Otto S; Winner B; Schöls L
    Neurology; 2006 Aug; 67(3):430-4. PubMed ID: 16894103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of a 32-item scale to assess postoperative dysfunction after upper gastrointestinal cancer resection.
    Nakamura M; Kido Y; Egawa T
    J Clin Nurs; 2008 Jun; 17(11):1440-9. PubMed ID: 18482141
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cross-cultural adaptation and validation of the International Cooperative Ataxia Rating Scale (ICARS) to Brazilian Portuguese.
    Maggi FA; Braga-Neto P; Chien HF; Gama MTD; Rezende Filho FM; Saraiva-Pereira ML; Jardim LB; Voos MC; Pedroso JL; Barsottini OGP
    Arq Neuropsiquiatr; 2018 Oct; 76(10):674-684. PubMed ID: 30427507
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Differential diagnosis of cerebellar ataxic syndromes in degenerative cerebellar diseases].
    Kulawik H
    Psychiatr Neurol Med Psychol (Leipz); 1971 Nov; 23(11):617-28. PubMed ID: 5145539
    [No Abstract]   [Full Text] [Related]  

  • 36. [Use of the WHODAS II with stroke patients and their relatives: reliability and inter-rater-reliability].
    Schlote A; Richter M; Wunderlich MT; Poppendick U; Möller C; Wallesch CW
    Rehabilitation (Stuttg); 2008 Feb; 47(1):31-8. PubMed ID: 18247269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reliability and validity of the center for epidemiologic studies depression scale in patients with systemic sclerosis.
    Thombs BD; Hudson M; Schieir O; Taillefer SS; Baron M;
    Arthritis Rheum; 2008 Mar; 59(3):438-43. PubMed ID: 18311754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of Ataxia Rating Scales and Cerebellar Functional Tests: Critique and Recommendations.
    Perez-Lloret S; van de Warrenburg B; Rossi M; Rodríguez-Blázquez C; Zesiewicz T; Saute JAM; Durr A; Nishizawa M; Martinez-Martin P; Stebbins GT; Schrag A; Skorvanek M;
    Mov Disord; 2021 Feb; 36(2):283-297. PubMed ID: 33022077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coenzyme Q(10)-responsive ataxia: 2-year-treatment follow-up.
    Pineda M; Montero R; Aracil A; O'Callaghan MM; Mas A; Espinos C; Martinez-Rubio D; Palau F; Navas P; Briones P; Artuch R
    Mov Disord; 2010 Jul; 25(9):1262-8. PubMed ID: 20629161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Longitudinal tracking of gait and balance impairments in cerebellar disease.
    Morton SM; Tseng YW; Zackowski KM; Daline JR; Bastian AJ
    Mov Disord; 2010 Sep; 25(12):1944-52. PubMed ID: 20544808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.